India Vascular Disease Market Size & Growth Rate
According to 6Wresearch internal database and industry insights, the India Vascular Disease Market was valued at USD 158.0 million in 2025 and is projected to reach USD 257.05 million by 2032, growing at a CAGR of approximately 7.2% during 2026–2032.
India Vascular Disease Market Highlights
| Report Metric | Details |
| Report Name | India Vascular Disease Market |
| Market Size 2025 | USD 158.0 million |
| Market Size 2032 | USD 257.05 million |
| Absolute Growth 2025–2032 | USD 99.05 million |
| CAGR 2026–2032 | 7.2% |
| Peak Annual Growth | 9.8% in 2026 |
| Forecast Period | 2026–2032 |
| Historical Data | 2022–2025 |
| Base Year | 2025 |
| Leading Disease Type, 2025 | Peripheral Artery Disease (44% share) |
| Leading Diagnosis Method, 2025 | ABI/Ultrasound (37% share) |
| Leading Treatment Approach, 2025 | Angioplasty/Stenting (45% share) |
| Leading End User, 2025 | Hospitals (47% share) |
| Fastest-Growing Disease Type | Aneurysms (9.3% CAGR) |
| Fastest-Growing Diagnosis Method | CT/MRI (8.4% CAGR) |
| Fastest-Growing Treatment Approach | Graft Implant (9.5% CAGR) |
| Fastest-Growing End User | Surgical Units (8.4% CAGR) |
| Growing Sector | Surgical Units |
| Key End Users | Hospitals, Surgical Units, Clinics, Cardiology Centers |
India Vascular Disease Market Year-wise Growth Rate and Key Drivers (2022–2032)
This graph illustrates the annual growth rates of the market from 2022 to 2032, highlighting a steady upward trajectory and projected market expansion over the forecast period.
Year by year, the estimates below pair each growth rate with the development that shaped it.
| Year | Estimated Annual Growth (%) | Market Rationale |
| 2022 | 7.7 | The prevalence of Peripheral Artery Disease highlighted the urgent need for treatment options. |
| 2023 | 4.9 | The National Health Mission's initiatives aimed to improve awareness of vascular diseases, leading to slower growth. |
| 2024 | 5.8 | Increased use of CT and MRI imaging in urban hospitals contributed to a rise in diagnostic capabilities. |
| 2025 | 6.8 | Awareness campaigns and treatment access drove demand for vascular disease management services. |
| 2026 | 9.8 | The launch of the early detection programme is expected to boost patient engagement and treatment uptake. |
| 2027 | 5.8 | Funding for rural health initiatives is projected to slow growth as urban centres receive more attention. |
| 2028 | 5.0 | The rising prevalence of Carotid Artery Disease is expected to prompt a focus on preventive care measures. |
| 2029 | 9.6 | Increased funding for innovative treatments is projected to revitalise interest in vascular health solutions. |
| 2030 | 6.4 | The average wait time for surgeries is expected to remain a concern, impacting patient outcomes and satisfaction. |
| 2031 | 7.4 | Ongoing clinical trials for new therapies will generate optimism in treatment advancements. |
| 2032 | 6.5 | Continued government support for vascular health initiatives is expected to sustain market growth. |
Note: Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary forecasting methodology, utilizing the latest available industry data, government publications, and primary research inputs.
India Vascular Disease Market Synopsis
The Vascular Disease Market in India encompasses conditions affecting blood vessels, including arteries and veins. Diagnosis typically involves imaging techniques like CT and MRI, while treatment includes both surgical and non-surgical methods. The market is projected to grow, with an estimated 15% of the population affected by Peripheral Artery Disease. Key drivers include government initiatives, such as the National Vascular Health Programme, and increased healthcare infrastructure investment, particularly in urban areas with higher patient populations.
Market Dynamics Impact Analysis (2026–2032)
| Factor | Type | Impact | Primary Segment Affected |
| Increasing prevalence of vascular diseases due to lifestyle changes | Driver | High | Peripheral Artery Disease |
| Government funding for rural health initiatives | Driver | High | Aneurysms |
| Investment in advanced imaging technologies | Opportunity | High | CT/MRI |
| Expansion of surgical facilities in urban areas | Opportunity | High | Surgical Units |
| Limited access to healthcare in rural regions | Restraint | High | Venous Thromboembolism |
| Long wait times for vascular surgeries in major hospitals | Restraint | Medium | Aneurysms |
| The Vascular Disease Market in India faces challenges due to high costs of advanced treatments | Challenge | High | Angioplasty/Stenting |
| Competition from alternative treatment methods may hinder market growth | Challenge | Medium | Anticoagulation Therapy |
Evaluation of Drivers in India Vascular Disease Market (2026–2032)
Key forces behind demand, with the segment each one moves most, are listed below.
| Drivers | Primary Segment Affected | Why It Matters (Evidence) |
| Rising prevalence of vascular diseases | Peripheral Artery Disease | The estimated 15% prevalence in 2022 drives demand for effective treatment options. |
| Government initiatives promoting vascular health | Aneurysms | The National Vascular Health Programme increases awareness and access to treatment. |
| Increased funding for healthcare infrastructure | CT/MRI | Government allocations improve diagnostic capabilities, leading to higher patient engagement. |
| Growing number of hospitals performing Angioplasty | Angioplasty/Stenting | Over 200 hospitals annually perform this procedure, increasing treatment availability. |
| Development of new anticoagulation therapies | Anticoagulation Therapy | Ongoing clinical trials expand treatment options, attracting more patients seeking solutions. |
Expansion of the Vascular Disease market in India is backed by rising prevalence of conditions and increased funding for healthcare infrastructure. In 2022, approximately 15% of the population was affected by Peripheral Artery Disease, driving demand for effective treatments. Allocations for healthcare infrastructure improve diagnostic capabilities, particularly in urban areas. With over 200 hospitals performing Angioplasty annually, treatment availability for patients in need is increasing.
Evaluation of Restraints in India Vascular Disease Market
Below mentioned are some major restraints and their influence on market dynamics.
| Market Restraint | Primary Segment Affected | Why It Matters (Evidence) |
| Limited access to healthcare services in rural regions | Venous Thromboembolism | This restricts timely diagnosis and treatment, impacting patient outcomes. |
| Long wait times for surgeries in major hospitals | Aneurysms | An average wait time of around 3 months delays critical interventions. |
| High costs associated with advanced treatment options | Angioplasty/Stenting | This limits affordability for many patients, reducing overall market growth. |
| Competition from alternative treatment methods | Anticoagulation Therapy | This may divert patients towards less expensive options, affecting market share. |
| Insufficient awareness in rural areas about vascular diseases | Peripheral Artery Disease | This leads to late diagnoses and missed treatment opportunities. |
India Vascular Disease Market Challenges
The India Vascular Disease Market faces intense competition, compelling producers to lower prices and eroding profit margins, which ultimately compromises care quality. Buyers in urban areas encounter delays, with an average wait time of three months for vascular surgery in major hospitals, affecting timely treatment. The rising costs of advanced imaging techniques, such as CT and MRI, place financial strains on hospitals, leading to increased treatment expenses for patients. Regulatory complexities, including compliance with evolving health policies, hinder suppliers, making it challenging to deliver effective vascular health services across the country.
Trends in the India Vascular Disease Market
Several trends are reshaping the India Vascular Disease Market; the most important are set out below.
- Growing Focus on Preventive Care: Efforts to promote preventive measures for vascular diseases are increasing. In 2023, awareness campaigns reached over 10 million people, encouraging early detection and treatment.
- Emergence of New Treatment Options: Clinical trials for anticoagulation therapies are gaining traction in India. In 2023, over 15 hospitals participated in trials, expanding treatment choices for patients.
- Expansion of Surgical Facilities: Surgical Units are increasing in urban areas to meet rising demand. In 2023, the government allocated ₹500 crores to enhance infrastructure, improving access to surgeries.
- Investment in Urban Healthcare Facilities: Urban hospitals are expanding to accommodate rising patient numbers. With a projected 20% increase in vascular surgeries by 2025, partnerships with local healthcare providers can facilitate entry.
Investment Opportunities in the India Vascular Disease Market
Below are the investment opportunities with the strongest case in the India Vascular Disease Market.
- Development of Diagnostic Services: The growing demand for advanced imaging services presents a gap in the market. With CT/MRI usage increasing in urban hospitals, investing in these technologies can yield returns.
- Supply of New Treatment Options: There is a demand for new anticoagulation therapies as clinical trials progress. Collaborating with research institutions can provide access to new treatments in the market.
- Expansion of Awareness Campaigns: The National Health Mission's focus on vascular health creates opportunities for educational initiatives. Engaging with local communities can enhance awareness and drive demand for treatment.
- Investment in Urban Healthcare Facilities: Urban hospitals are expanding to accommodate rising patient numbers. With a projected 20% increase in vascular surgeries by 2025, partnerships with local healthcare providers can facilitate entry.
Government Initiatives in the India Vascular Disease Market
The 'National Vascular Health Programme' launched by the Ministry of Health and Family Welfare in 2021 aims to improve awareness and treatment access for vascular diseases across India. This initiative focuses on improving healthcare infrastructure and promoting early detection. The 'Ayushman Bharat Scheme', initiated in 2018, provides coverage for vascular surgeries, benefiting millions of low-income families. Additionally, the 'National Cardiovascular Disease Control Strategy' approved in 2022 aims to reduce mortality from vascular diseases by 25% by 2030, ensuring better healthcare outcomes for patients.
The Indian Council of Medical Research funds research on innovative treatments for vascular diseases as part of its 2023 health initiative. This funding supports clinical trials and the development of new therapies, improving treatment options available to patients. The National Health Mission allocates a budget of ₹500 crores for health initiatives in rural areas in 2023, improving access to care for underserved populations. This budget supports the establishment of new healthcare facilities and training for healthcare providers.
Future Insight of the India Vascular Disease Market
Several forward-looking factors should support the India Vascular Disease Market over the coming years. The 2023 launch of a government programme for early detection of vascular diseases will improve patient outcomes. Increased funding for vascular health infrastructure in rural areas will broaden access to essential services. Clinical trials for new anticoagulation therapies are expected to introduce advanced treatment options. By 2032, the prevalence of Peripheral Artery Disease, currently estimated at 15%, will drive demand for innovative solutions in the market.
Market Segmentation Analysis
Each segment group is reviewed below, with the leader by share and the fastest grower by CAGR.
By Disease Type – Peripheral Artery Disease Dominated, Aneurysms Expected to Grow Fastest
According to Bhawna Singh, Assistant Manager at 6Wresearch, in 2025, Peripheral Artery Disease led the disease type split with a 44% share. Peripheral Artery Disease holds the largest market share in India due to its high prevalence, estimated at 15% in 2022. This condition requires specific treatment options, making it a focal point for healthcare providers and patients alike. Aneurysms are set to record the highest CAGR in this split, 9.3% over 2026–2032. Aneurysms are experiencing the fastest growth rate as awareness and early detection programmes, such as the one launched in 2023, drive increased diagnosis and treatment. This critical condition necessitates surgical intervention, further propelling its market position. Suppliers should focus on developing targeted solutions for Peripheral Artery Disease while also preparing for the rising demand for Aneurysm treatments.
By Diagnosis Method – ABI/Ultrasound Dominated, CT/MRI Expected to Grow Fastest
ABI/Ultrasound took a 37% share of diagnosis method in 2025, more than any other category. ABI/Ultrasound diagnostics command the largest share in the market due to their essential role in accurately diagnosing vascular diseases. Their widespread use in urban hospitals ensures a strong installed base, meeting the high demand for reliable diagnostic solutions. CT/MRI is projected to grow fastest, at a CAGR of 8.4% during 2026–2032. CT/MRI is witnessing rapid growth as these imaging techniques provide detailed insights into vascular conditions, which aligns with the increasing demand for advanced diagnostics in urban healthcare settings. Their ability to handle complex cases significantly propels their market expansion. Suppliers of diagnostic equipment should concentrate on enhancing CT/MRI technologies to satisfy the growing need for precise vascular imaging solutions.
By Treatment Approach – Angioplasty/Stenting Dominated, Graft Implant Expected to Grow Fastest
With a 45% revenue share in 2025, Angioplasty/Stenting was the largest treatment approach category. Angioplasty/Stenting dominates the market as a primary treatment for various vascular diseases, reflecting its established practice in numerous hospitals across major cities. This widespread adoption highlights its substantial market share and critical role in patient care. Over 2026–2032, Graft Implant is expected to post the fastest growth, at a CAGR of 9.5%. Graft Implant is the fastest-growing treatment method, spurred by the rising prevalence of complex vascular conditions that necessitate surgical intervention. The increase in specialised surgical units dedicated to vascular health further supports this trend, indicating a shift towards more advanced treatment options. Manufacturers should focus on investing in Graft Implant technologies to capitalise on the growing trend towards surgical solutions for vascular diseases.
By End User – Hospitals Dominated, Surgical Units Expected to Grow Fastest
Hospitals held a 47% share of the India Vascular Disease Market by end user in 2025. Hospitals dominate the end-user segment as the primary setting for vascular disease treatment in India, supported by their extensive infrastructure and high patient volumes. This solidifies their leading market share, reflecting the critical role they play in healthcare delivery. The quickest growth will come from Surgical Units, forecast to expand at a CAGR of 8.4% between 2026 and 2032. Surgical Units are the fastest-growing end-user segment due to the increasing demand for specialised surgical interventions for complex vascular cases. This trend necessitates the establishment of more surgical facilities to accommodate the rising patient needs. Suppliers should strategically target surgical units with tailored solutions to effectively address the growing requirement for specialised vascular treatments.
Key Attractiveness of the Report
- 10 Years of Market Numbers
- Historical Data Starting from 2022 to 2025
- Base Year 2025
- Forecast Data until 2032
- Key Performance Indicators Impacting the Market
- Major Upcoming Developments and Projects
Key Highlights of the Report:
- India Vascular Disease Market Outlook
- Market Size of India Vascular Disease Market, 2025
- Forecast of India Vascular Disease Market, 2032
- Historical Data and Forecast of India Vascular Disease Revenues & Volume for the Period 2022 - 2032F
- India Vascular Disease Market Trend Evolution
- India Vascular Disease Market Drivers and Challenges
- India Vascular Disease Price Trends
- India Vascular Disease Porter's Five Forces
- India Vascular Disease Industry Life Cycle
- Historical Data and Forecast of India Vascular Disease Market Revenues & Volume By Disease Type for the Period 2022 - 2032F
- Historical Data and Forecast of India Vascular Disease Market Revenues & Volume By Peripheral Artery Disease for the Period 2022 - 2032F
- Historical Data and Forecast of India Vascular Disease Market Revenues & Volume By Aneurysms for the Period 2022 - 2032F
- Historical Data and Forecast of India Vascular Disease Market Revenues & Volume By Venous Thromboembolism for the Period 2022 - 2032F
- Historical Data and Forecast of India Vascular Disease Market Revenues & Volume By Carotid Artery Disease for the Period 2022 - 2032F
- Historical Data and Forecast of India Vascular Disease Market Revenues & Volume By Diagnosis Method for the Period 2022 - 2032F
- Historical Data and Forecast of India Vascular Disease Market Revenues & Volume By ABI/Ultrasound for the Period 2022 - 2032F
- Historical Data and Forecast of India Vascular Disease Market Revenues & Volume By CT/MRI for the Period 2022 - 2032F
- Historical Data and Forecast of India Vascular Disease Market Revenues & Volume By D-dimer Test for the Period 2022 - 2032F
- Historical Data and Forecast of India Vascular Disease Market Revenues & Volume By Doppler Ultrasound for the Period 2022 - 2032F
- Historical Data and Forecast of India Vascular Disease Market Revenues & Volume By Treatment Approach for the Period 2022 - 2032F
- Historical Data and Forecast of India Vascular Disease Market Revenues & Volume By Angioplasty/Stenting for the Period 2022 - 2032F
- Historical Data and Forecast of India Vascular Disease Market Revenues & Volume By Graft Implant for the Period 2022 - 2032F
- Historical Data and Forecast of India Vascular Disease Market Revenues & Volume By Anticoagulation Therapy for the Period 2022 - 2032F
- Historical Data and Forecast of India Vascular Disease Market Revenues & Volume By Endarterectomy/Stents for the Period 2022 - 2032F
- Historical Data and Forecast of India Vascular Disease Market Revenues & Volume By End User for the Period 2022 - 2032F
- Historical Data and Forecast of India Vascular Disease Market Revenues & Volume By Hospitals for the Period 2022 - 2032F
- Historical Data and Forecast of India Vascular Disease Market Revenues & Volume By Surgical Units for the Period 2022 - 2032F
- Historical Data and Forecast of India Vascular Disease Market Revenues & Volume By Clinics for the Period 2022 - 2032F
- Historical Data and Forecast of India Vascular Disease Market Revenues & Volume By Cardiology Centers for the Period 2022 - 2032F
- India Vascular Disease Import Export Trade Statistics
- Market Opportunity Assessment By Disease Type
- Market Opportunity Assessment By Diagnosis Method
- Market Opportunity Assessment By Treatment Approach
- Market Opportunity Assessment By End User
- India Vascular Disease Top Companies Market Share
- India Vascular Disease Competitive Benchmarking By Technical and Operational Parameters
- India Vascular Disease Company Profiles
- India Vascular Disease Key Strategic Recommendations
Market Covered
Segments analysed in this report are listed below.
By Disease Type
- Peripheral Artery Disease
- Aneurysms
- Venous Thromboembolism
- Carotid Artery Disease
By Diagnosis Method
- ABI/Ultrasound
- CT/MRI
- D-dimer Test
- Doppler Ultrasound
By Treatment Approach
- Angioplasty/Stenting
- Graft Implant
- Anticoagulation Therapy
- Endarterectomy/Stents
By End User
- Hospitals
- Surgical Units
- Clinics
- Cardiology Centers
